|
1）日本胃癌学会，編．胃癌治療ガイドライン第3版．東京: 金原出版; 2010
|
|
|
|
|
2）Fujitani K, Yang HK, Kurokawa Y, et al. Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single noncurable factor: Japan clinical oncology group study JCOG 0705 and Korea gastric cancer association study KGCA01. Jpn J Clin Oncol. 2008; 38: 504-6
|
|
|
|
|
3）日本胃癌学会，編．第14版胃癌取扱い規約．東京: 金原出版; 2010
|
|
|
|
|
|
4）Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma. 3rd English edition. Gastric Cancer. 2011; 14: 101-12
|
|
|
|
|
|
5）Edge SB, Byrd DR, Compton CC, et al. American Joint Committee on Cancer (AJCC) cancer staging manual. 7th ed. Chicago: Springer; 2010
|
|
|
|
|
|
6）Sobin LH, Gospodarowicz MK, Wittekind CH. TNM classification of malignant tumours. 7th ed. New York: Wiley-Blackwell; 2009
|
|
|
|
|
|
7）Bentrem D, Wilton A, Mazumdar M, et al. The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection. Ann Surg Oncol. 2005; 12: 347-53
|
|
|
|
|
|
8）Mezhir JJ, Shah MA, Jacks LM, et al. Positive peritoneal cytology in patients with gastric cancer: natural history and outcome of 291 patients. Ann Surg Oncol. 2010; 17: 3173-80
|
|
|
|
|
|
9）Fukagawa T, Katai H, Saka M, et al. Significance of lavage cytology in advanced gastric cancer patients. World J Surg. 2010; 34: 563-8
|
|
|
|
|
|
10）Lee SD, Ryu KW, Eom BW, et al. Prognostic significance of peritoneal washing cytology in patients with gastric cancer. Br J Surg. 2012; 99: 397-403
|
|
|
|
|
|
11）Leake PA, Cardoso R, Seevaratnam R, et al. A systematic review of the accuracy and utility of peritoneal cytology in patients with gastric cancer. Gastric Cancer. 2011. Epub ahead of print
|
|
|
|
|
|
12）Kodera Y, Ito S, Mochizuki Y, et al. A phase II study of radical surgery followed by post-operative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study). Eur J Surg Oncol. 2009; 35: 1158-63
|
|
|
|
|
|
13）Koizumi W, Narahara H, Hara T, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008; 9: 215-21
|
|
|
|
|
|
14）Takahari D, Hamaguchi T, Yoshimura K, et al. Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer. Cancer Chemother Pharmacol. 2011; 67: 1423-8
|
|
|
|
|
|
15）Kim YH, Koizumi W, Lee KH, et al. Randomized phase III study of S-1 alone versus S-1+docetaxel in the treatment for advanced gastric cancer (The START trial). ASCO-GI proceedings: abstr 7, 2011
|
|
|
|
|
|
16）Tamura S, Fujitani K, Kimura Y, et al. Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy. Oncology. 2011; 80: 296-300
|
|
|
|
|
|
17）Kuramoto M, Shimada S, Ikeshima S, et al. Extensive intraoperative peritoneal lavage as a standard prophylactic strategy for peritoneal recurrence in patients with gastric carcinoma. Ann Surg. 2009; 250: 242-6
|
|
|
|
|
|
18）Okabe H, Ueda S, Obama K, et al. Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. Ann Surg Oncol. 2009; 16: 3227-36
|
|
|
|
|
|
19）Satoh S, Okabe H, Teramukai S, et al. Phase II trial of combined treatment consisting of preoperative S-1 plus cisplatin followed by gastrectomy and postoperative S-1 for stage IV gastric cancer. Gastric Cancer. 2012; 15: 61-9
|
|
|
|
|
|
20）Ishigami H, Kitayama J, Kaisaki S, et al. Phase II study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer with peritoneal metastasis. Ann Oncol. 2010; 21: 67-70
|
|
|
|
|
|
21）Badgwell B, Cormier JN, Krishnan S, et al. Does neoadjuvant treatment for gastric cancer patients with positive peritoneal cytology at staging laparoscopy improve survival? Ann Surg Oncol. 2008; 15: 2684-91
|
|
|
|
|
|
22）Lorenzen S, Panzram B, Rosenberg R, et al. Prognostic significance of free peritoneal tumor cells in the peritoneal cavity before and after neoadjuvant chemotherapy in patients with gastric carcinoma undergoing potentially curative resection. Ann Surg Oncol. 2010; 17: 2733-9
|
|
|
|
|